Telix Pharmaceuticals Limited (TLX)
NASDAQ: TLX · Real-Time Price · USD
7.76
+0.33 (4.44%)
At close: Jan 16, 2026, 4:00 PM EST
7.84
+0.08 (1.03%)
After-hours: Jan 16, 2026, 7:33 PM EST
Telix Pharmaceuticals Market Cap
Telix Pharmaceuticals has a market cap or net worth of $2.6 billion as of January 16, 2026. Its market cap has decreased by -49.74% in one year.
Market Cap
2.60B
Enterprise Value
2.81B
1-Year Change
-49.74%
Ranking
Category
Stock Price
$7.76
Market Cap Chart
Since November 15, 2017, Telix Pharmaceuticals's market cap has increased from $115.28M to $2.60B, an increase of 2,154.04%. That is a compound annual growth rate of 46.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 2.60B | 2.67% |
| Dec 31, 2025 | 2.53B | -50.36% |
| Dec 31, 2024 | 5.10B | 129.18% |
| Dec 29, 2023 | 2.22B | 42.30% |
| Dec 30, 2022 | 1.56B | -2.70% |
| Dec 31, 2021 | 1.61B | 96.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 15, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 926.26B |
| Johnson & Johnson | 527.92B |
| AbbVie | 384.65B |
| UnitedHealth Group | 305.71B |
| AstraZeneca | 291.28B |
| Novartis AG | 278.73B |
| Merck & Co. | 275.23B |
| Novo Nordisk | 262.20B |